GENENTA SCIENCE SPA - ADR (GNTA) Forecast, Price Target & Analyst Ratings
NASDAQ:GNTA • US36870W1009
0.9101 USD
-0.01 (-1.31%)
At close: Mar 4, 2026
0.9101 USD
0 (0%)
Pre-Market: 3/5/2026, 4:54:34 AM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for GENENTA SCIENCE SPA - ADR (GNTA).
Forecast Snapshot
Consensus Price Target
$7.14
+ 684.53% Upside
Next Earnings Forecast
Release DateN/A
ChartMill Buy Consensus
82.86%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$7.14
Upside
+ 684.53%
From current price of $0.91 to mean target of $7.14, Based on 7 analyst forecasts
Low
$7.07
Median
$7.14
High
$7.35
Price Target Revisions
1 Month
-66.67%
3 Months
-66.67%
Price Target Summary
7 analysts have analysed GNTA and the average price target is 7.14 USD. This implies a price increase of 684.53% is expected in the next year compared to the current price of 0.9101.
The average price target has been revised downward by 66.67% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
GNTA was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about GNTA.
In the previous month the buy percentage consensus was at a similar level.
GNTA was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-10-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-02-08 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-01-05 | EF Hutton | Initiate | Buy |
| 2022-07-25 | HC Wainwright & Co. | Initiate | Buy |
| 2022-01-13 | Maxim Group | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateN/A
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | |||||||
| EBITDA YoY % growth | -4.62M | -5.59M -21.00% | -5.69M -1.79% | -11.03M -93.85% | -11.69M -5.99% | -9.72M 16.86% | N/A -242.80% | N/A | N/A | |
| EBIT YoY % growth | -4.62M | -5.59M -21.00% | -5.69M -1.79% | -11.04M -94.02% | -11.733M -6.28% | -9.764M 16.78% | N/A -9.45% | N/A -35.63% | N/A -40.00% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A 34.60% | N/A -115.72% | N/A 13.33% | N/A 20.00% | N/A 11.54% | N/A -15.22% |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
5.81%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
GENENTA SCIENCE SPA - ADR / GNTA Forecast FAQ
What do analysts expect the price target to be for GENENTA SCIENCE SPA - ADR (GNTA)?
7 analysts have analysed GNTA and the average price target is 7.14 USD. This implies a price increase of 684.53% is expected in the next year compared to the current price of 0.9101.
How do analysts rate GENENTA SCIENCE SPA - ADR (GNTA)?
The consensus rating for GENENTA SCIENCE SPA - ADR (GNTA) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.